Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Camostat Mesilate on COVID-19 Infection: An Investigator-initiated Randomized, Placebo-controlled, Phase IIa Trial

NCT04321096 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT04321096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04321096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Camostat Mesilate on COVID-19 Infection: An Investigator-initiated Randomized, Placebo-controlled, Phase IIa Trial
Lead sponsor
University of Aarhus
Phase
Phase 1/2
Overall status
Completed
Start date
April 4, 2020
Completion date
May 1, 2023
Enrollment
206 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection